This event will link CRISPR research leaders, postdocs and students across Australia, providing a multidisciplinary forum to discuss emerging CRISPR technology and its application to advancing medical research.
Alongside an all-star local speaker lineup, this symposium will feature keynote talks from two international speakers (Dr Dana Foss, USA, and Dr Ben Haley, Canada) and two national speakers (Dr Pilar Blancafort, WA, and Phenomics Australia Scientific Leader Professor Paul Thomas, SA).
This symposium has attracted a broad audience from the Melbourne biomedical precinct, with registrants from the Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute of Medical Research (WEHI), Olivia Newton-John Cancer Research Institute, Monash Biomedicine Discovery Institute, La Trobe University, and Peter Doherty Institute for Infection and Immunity, as well as the Children’s Cancer Institute in NSW.
With an established track record and reputation for excellence, Phenomics Australia Genome Engineering team uses techniques such as CRISPR-mediated mutagenesis, classical gene targeting, and transgenesis to create optimal tools for your research delivering a comprehensive service in genome modification. To meet the high demand for this platform, Phenomics Australia offers genome editing services through four nodes across Australia, operating at Monash, ANU, WEHI, and SAHMRI.